China Regenerative Medicine International Ltd

08158

Company Profile

  • Business description

    China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.

  • Contact

    132 Nathan Road
    Suite 2310-2318, Miramar Tower
    Tsim Sha Tsui
    Kowloon
    HKG

    T: +852 39189000

    https://www.crmi.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    30

Stocks News & Analysis

stocks

Avoid this overvalued ASX lithium producer

Why the market may be overpricing future earnings for this lithium producer.
stocks

Morningstar's verdict on SpaceX

Mark and Shani run through the business and what our analysts think about the IPO.
stocks

More problems for WiseTech

Our view of police investigation into chairman Richard White.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,012.6010.700.12%
CAC 408,385.4944.780.54%
DAX 4024,740.36153.22-0.62%
Dow JONES (US)51,848.90182.060.35%
FTSE 10010,461.6332.780.31%
HKSE23,412.1875.900.33%
NASDAQ25,476.64110.40-0.43%
Nikkei 22569,174.97613.41-0.88%
NZX 50 Index13,400.6635.11-0.26%
S&P 5007,358.227.24-0.10%
S&P/ASX 2008,808.407.000.08%
SSE Composite Index4,110.814.560.11%

Market Movers